Ivermectin: A positive allosteric effector of the α7 neuronal nicotinic acetylcholine receptor

Molecular Pharmacology

Volumn 53, Issue 2, 1998, Pages 283-294

  Krause, Ryoko M ^a   Buisson, Bruno ^a   Bertrand, Sonia ^a   Corringer, Pierre Jean ^b   Galzi, Jean Luc ^b,c   Changeux, Jean Pierre ^b   Bertrand, Daniel ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b INSTITUT PASTEUR   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR; IVERMECTIN; NICOTINIC RECEPTOR;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CHICKEN; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG RECEPTOR BINDING; HUMAN; NERVE CELL; NONHUMAN; OOCYTE; PRIORITY JOURNAL; XENOPUS LAEVIS;

EID: 0031887759     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.2.283     Document Type: Article

References (40)

1. Bertrand D, Bertrand S, and Ballivet M (1992) Pharmacological properties of the homomeric alpha 7 receptor. Neurosci Lett 146:87-90.
2. Bertrand D, Buisson B, Krause RM, Hu H-Y, and Bertrand S (1997) Electrophysiology: a method to investigate the functional properties of ligand-gated channels. J Recept Signal Transd Res 17:227-242.
3. Bertrand D and Changeux JP (1995) Nicotinic receptor: an allosteric protein specialized for intercellular communication. Semin Neurosci 7:75-90.
4. Bertrand D, Cooper E, Valera S, Rungger D, and Ballivet M (1991a) Electrophysiology of neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes following nuclear injection of genes or cDNA, in Methods in Neuroscience (Conn M, ed) pp 174-193, Academic Press, New York.
5. Bertrand D, Galzi JL, Devillers-Thiéry A, Bertrand S, and Changeux JP (1993) Mutations at two distinct sites within the channel domain M2 alter calcium permeability of neuronal alpha 7 nicotinic receptor. Proc Natl Acad Sci USA 90:6971-6975.
6. Bertrand D, Valera S, Bertrand S, Ballivet M, and Rungger D (1991b) Steroids inhibit nicotinic acetylcholine receptors. Neuroreport 2:277-280.
7. Bertrand S, Devillers-Thiéry A, Palma E, Buisson B, Edelstein SJ, Corringer PJ, Changeux JP, and Bertrand D (1997) Paradoxical allosteric effects of competitive inhibitors on neuronal α7 nicotinic acetylcholine receptor. Neuroreport 8:3591-3595.
8. Buisson B and Bertrand D (1998) Steroid modulation of the nicotinic acetylcholine receptor, in Comparative Endocrinology (Conn M, ed) Humana Press, Totowa, NJ.
9. Burg RW, Miller BM, Baker EE, Birnbaum J, Currie SA, Hartman R, Kong Y-L, Monaghan RL, Olson G, Putter I, Tunac JB, Wallick H, Stapley EO, Oiwa R, and Omura S (1979) Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob Agents Chemother 15:361-367.
10. Campbell WC (1989) Ivermectin and Abamectin. Springer-Verlag, New York.
11. Couturier S, Bertrand D, Matter JM, Hernandez MC, Bertrand S, Millar N, Valera S, Barkas T, and Ballivet M (1990) A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. Neuron 5:847-56.
12. Cully DF, Vassilatis DK, Liu KK, Paress PS, Van der Ploeg LHT, Schaeffer JM, and Arena JP (1994) Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegans. Nature (Lond) 371:707-711.
13. Delbono O, Gopalakrishnan M, Renganathan M, Monteggia LM, Messi ML, and Sullivan JP (1997) Activation of the recombinant human alpha-7 nicotinic acetylcholine receptor significantly raises intracellular free calcium. J Pharmacol Exp Ther 280:428-438.
14. Devillers-Thiéry A, Galzi JL, Bertrand S, Changeux JP, and Bertrand D (1992) Stratified organization of the nicotinic acetylcholine receptor channel. Neuroreport 3:1001-1004.
15. Galzi JL, Bertrand S, Corringer PJ, Changeux JP, and Bertrand D (1996a) Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor. EMBO J 15:5824-5832.
16. Galzi JL, Devillers-Thiéry A, Hussy N, Bertrand S, Changeux JP, and Bertrand D (1992) Mutations in the ion channel domain of a neuronal nicotinic receptor convert ion selectivity from cationic to anionic. Nature (Lond) 359:500-505.
17. Galzi JL, Edelstein SJ, and Changeux JP (1996b) The multiple phenotypes of allosteric receptor mutants. Proc Natl Acad Sci USA 93:1853-1858.
18. Gopalakrishnan M, Buisson B, Touma E, Giordano T, Campbell JE, Hu IC, Donnely-Roberts D, Arneric SP, Bertrand D, and Sullivan JP (1995) Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptor. Eur J Pharmacol Mol 290:237-246.
19. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, and Dani JA (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature (Lond) 383:713-716.
20. Krusek J and Zemková H (1994) Effect of ivermectin on γ-aminobutyric acid-induced chloride currents in mouse hippocampal embryonic neurones. Eur J Pharmacol 259:121-128.
21. 2+; ions in nicotinic facilitation of GABA release in mouse thalamus. J Neurosci 17:576-585.
22. Lindstrom J (1996) Neuronal nicotinic acetylcholine receptors, in Ion Channels. (Narahashi T, ed) pp 377-450, Plenum Press, New York.
23. Mahmoud AAF (1995) Diseases due to helminths, in Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases (Mandell GL, Bennett JE, and Dolin R, eds) pp 2525-2537, Churchill Livingstone, New York.
24. Monod J, Wyman J, and Changeux JP (1965) On the nature of allosteric transitions: a plausible model. J Mol Biol 12:88-118.
25. Mulle C, Lêna C, and Changeux JP (1992) Potentiation of nicotinic receptor response by external calcium in rat central neurons. Neuron 8:937-945.
26. Ottesen EA and Campbell WC (1994) Ivermectin in human medicine. J Antimicrob Chemother 34:195-203.
27. Pacqué M, Muñoz B, Greene BM, and Taylor HR (1991) Community-based treatment of onchocerciasis with ivermectin: safety, efficacy, and acceptability of yearly treatment. J Inf Dis 163:381-385.
28. Palma E, Bertrand S, Binzoni T, and Bertrand D (1996) Neuronal nicotinic α7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine. J Physiol (Lond) 491:151-161.
29. Peng X, Katz M, Gerzanich V, Anand R, and Lindstrom J (1994) Human α7 acetylcholine receptor: cloning of the α7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional α7 homomers expressed in Xenopus oocytes. Mol Pharmacol 45:546-554.
30. Perutz MF, Fermi G, Abraham G, Poyart C, and Bursaux E (1986) Hemoglobin as a receptor of drugs and peptides: x-ray studies of the stereochemistry of binding. J Am Chem Soc 108:1064-1078.
31. A receptors. Neuron 4:759-765.
32. A receptor research. Synapse 21:189-274.
33. Revah F, Bertrand D, Galzi JL, Devillers-Thiéry A, Mulle C, Hussy N, Bertrand S, Ballivet M, and Changeux JP (1991) Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor. Nature (Lond) 353:846-849.
34. Rubin MM and Changeux JP (1966) On the nature of allosteric transitions: implications of nonexclusive ligand binding. J Mol Biol 21:265-274.
35. - channels by avermectin in rat cultured hippocampal neurons. Arch Pharm 348:628-632.
36. Sigel E and Baur R (1987) Effect of Avermectin B1a on chick neuronal γ-aminobutyrate receptor channels expressed in Xenopus oocytes. Mol Pharmacol 32:749-752.
37. Valera S, Ballivet M, and Bertrand D (1992) Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 89:9949-9953.
38. Warpman U and Nordberg A (1995) Epibatidine and ABT 418 reveal selective losses of alpha4 beta2 nicotinic receptors in Alzheimer brains. Neuroreport 6:2419-2423.
39. Wevers A, Sullivan JP, Giordano T, Birtsch C, Monteggia LM, Nowacki S, Arneric S, and Schroder H (1995) Cellular distribution of the mRNA for the alpha 7 subunit of the nicotinic acetylcholine receptor in the human cerebral cortex. Drug Dev Res 36:103-110.
40. Wonnacott S, Albuquerque EX, and Bertrand D (1993) Methyllycaconitine: a new probe that discriminates between nicotinic acetylcholine receptor subclasses, in Receptors: Molecular Biology, Receptor Subclasses, Localization, and Ligand Design (Conn PM, ed) pp 263-275, Academic Press, New York.